TScan Therapeutics TCRX
NASDAQ TCRX
$0.14 -0.01 (-6.67%)
At close: Nov 19, 2026 · 4:00 PM EST

TScan Therapeutics (TCRX) EBIT Margin (2020 - 2026)

Updated

TScan Therapeutics' EBIT Margin was -5636.69% in Q3 2026, down 4161.10 percentage points from -1475.59% a year earlier and down 2735.36 percentage points from the prior quarter.

Analysis

TScan Therapeutics (TCRX) EBIT Margin (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, TScan Therapeutics' EBIT Margin was -2246.84% through Sep 30, 2026, down 481.83 percentage points year-over-year; for FY2025, it was -1315.38%, up 3472.30 percentage points from FY2024.

  • EBIT Margin shows a five-year change of +1102.41 percentage points (FY2020 to FY2025).
  • In earlier years, EBIT Margin was -4787.68% in FY2024 (-4343.68 pp), -444.00% in FY2023 (+48.32 pp), -492.32% in FY2022 (-12.68 pp) and -479.65% in FY2021 (+1938.14 pp).
  • The Q3 2026 figure marks the lowest quarterly EBIT Margin since Q2 2024.
  • Compared with a year earlier, EBIT Margin has declined for three straight quarters, with an average year-over-year change of +359.84 percentage points over the last eight quarters.
  • The best year-over-year quarter for EBIT Margin over five years was Q2 2025 (a gain of 5107.95 percentage points); the worst was Q2 2024 (a drop of 5582.79 percentage points).
  • Per Business Quant data, TCRX's EBIT Margin in the three quarters before Q3 2026 was -2901.33% (Q2 2026), -2967.31% (Q1 2026) and -929.41% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -907.40%
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 34.46%
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 24.35%
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 36.01%
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 30.74%
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 35.79%
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 41.71%
9 Gsk 193.54 Bn 176.38 Bn - -
10 TScan Therapeutics 18.87 Mn -434.83 Mn - -5,636.69%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -5,636.69%
Jun 30, 2026 -2,901.33%
Mar 31, 2026 -2,967.31%
Dec 31, 2025 -929.41%
Sep 30, 2025 -1,475.59%
Jun 30, 2025 -1,256.60%
Mar 31, 2025 -1,669.74%
Dec 31, 2024 -5,520.60%
Sep 30, 2024 -3,109.82%
Jun 30, 2024 -6,364.55%
Mar 31, 2024 -5,542.93%
Dec 31, 2023 -296.17%
Sep 30, 2023 -636.69%
Jun 30, 2023 -781.77%
Mar 31, 2023 -334.31%
Dec 31, 2022 -602.55%
Sep 30, 2022 -492.95%
Jun 30, 2022 -375.89%
Mar 31, 2022 -535.02%
Dec 31, 2021 -497.62%
API Access

TScan Therapeutics EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=TCRX&period=max&api_key=YOUR_API_KEY